NCENatonal tute forHealth and Care ExcellenceNICE贝guidanceAxicabtagene ciloleucel fortreating diffuse large B-celllymphoma and primarymediastinal large B-celllymphoma after 2 or moresystemic therapiesTechnology appraisal guidancePublished:28 February 2023www.nice.org.uk/quidance/ta872NICE 2023.All rights reserved.Subject to Notice of rights(https://www.nice.org.uk/terms-and-conditions#notice-of-rights).